Linno Pharmaceuticals Inc.
PrivateLast Round
Early Funding
Jul 18, 2022
Company Overview
Linno Pharmaceuticals Inc. is a biopharmaceutical company that develops therapies for severe, rare, and chronic diseases using its proprietary blood-brain barrier-penetrating drug delivery technology and next-generation complement inhibitors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Linno Pharmaceuticals Inc. Comparables
Compare Linno Pharmaceuticals Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omeros Corporation | 74% | |
| JCR Pharmaceuticals Co., Ltd. | 73% | |
| Novartis | 72% | |
Linno Pharmaceuticals Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 18, 2022 | ||||
| Angel | Nov 19, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2022
Completed an early funding round.
- Nov 19, 2019
Completed an angel funding round.
Linno Pharmaceuticals Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Linno Pharmaceuticals Inc.'s valuation, stock price, and market status.